25Nov/13

Treating deadly dog bites costs Baramulla man his lone kidney – GreaterKashmir.com


GreaterKashmir.com

Treating deadly dog bites costs Baramulla man his lone kidney
GreaterKashmir.com
Why so? “For a kidney transplant patient, immunity has to be suppressed to minimal low so that the body accepts the donor organ while immunization is exactly the opposite,” explained medicos. The medicos said they could only find three such cases

25Nov/13

Sonia Gandhi congratulates India's first liver transplant recipient – Parda Phash


Parda Phash

Sonia Gandhi congratulates India’s first liver transplant recipient
Parda Phash
enjoys meals, plays football and wants to become a doctor to save lives. Sanjay’s success helped establish liver transplantation in India,” said Anupam Sibal, senior paediatric gastroenterologist in the hospital. Babulal Nagar’s judicial custody
Sonia Gandhi felicitates liver transplant recipientBusiness Standard

all 3 news articles »

25Nov/13

UPA Chairperson Felicitates India's First Successful Liver Transplant … – PR Newswire India (press release)

UPA Chairperson Felicitates India’s First Successful Liver Transplant
PR Newswire India (press release)
UPA Chairperson and Congress Party President, Smt. Sonia Gandhi today felicitated India’s first successful liver transplant recipient, Sanjay Kandasamy from Kancheepuram, Tamil Nadu who had undergone a liver transplant in November 1998 at Apollo 

and more »

25Nov/13

US group opposes Gilead's patenting of hepatitis C drug in India – domain-B


Hindu Business Line

US group opposes Gilead’s patenting of hepatitis C drug in India
domain-B
US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir in India is facing opposition from a US legal group I-MAK (Initiative for Medicines, Access & Knowledge) on the ground that it is old known compound and has nothing new to
US group seeks to block Gilead drug patent in IndiaEconomic Times
US group against Gilead’s patent request in India for hepatitis C drugTopNews United States
Indian health activists move to prevent Gilead’s drug patentFinancial Times

all 94 news articles »

24Nov/13

Indian health activists move to prevent Gilead's drug patent – Financial Times


Geo News, Pakistan

Indian health activists move to prevent Gilead’s drug patent
Financial Times
The Initiative for Medicines, Access & Knowledge in India said it had filed a “pre-grant” application in Calcutta to block a patent application on the drug sofosbuvir, just as Gilead, the US pharmaceutical group that developed the medicine, won
US group seeks to block Gilead drug patent in IndiaGeo News, Pakistan

all 68 news articles »